nandrolone has been researched along with trelstar in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Audebert, A; Cosson, M; Donnez, J; Konincks, P; Madelenat, P; Manhes, H; Querleu, D | 1 |
| Fawzy, M; Mesbah, Y | 1 |
| Ceccarello, M; Ceccaroni, M; Clarizia, R; Donati, A; Ferrero, S; Liverani, S; Manzone, M; Roviglione, G | 1 |
2 trial(s) available for nandrolone and trelstar
| Article | Year |
|---|---|
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
Topics: Adolescent; Adult; Alkaline Phosphatase; Cholesterol; Cholesterol, HDL; Combined Modality Therapy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Triptorelin Pamoate | 2002 |
Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intestines; Laparoscopy; Leuprolide; Nandrolone; Pelvic Pain; Peritoneum; Postoperative Care; Pregnancy; Recurrence; Reoperation; Secondary Prevention; Treatment Outcome; Triptorelin Pamoate | 2021 |
1 other study(ies) available for nandrolone and trelstar
| Article | Year |
|---|---|
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
Topics: Adenomyosis; Administration, Oral; Adult; Endometriosis; Female; Humans; Injections, Subcutaneous; Menorrhagia; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Prospective Studies; Treatment Outcome; Triptorelin Pamoate | 2015 |